Alison McLean
Impact in
-
- Organ and Tissue Transplantation Research
-
- Biomedical Ethics and Regulation
Papers in
-
- Acute Myocardial Infarction Research 4
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Pluripotent Stem Cells Research 3
- Co-authors
- Ian Kerridge (3 shared papers)Cameron Stewart (3 shared papers)Fabio Luciani (1 shared paper)Mark M. Tanaka (1 shared paper)C. Juergens (4 shared papers)Sonya Burgess (3 shared papers)S. Lo (3 shared papers)C. Mussap (4 shared papers)
In The Last Decade
Alison McLean
12 papers receiving 102 citations
Peers
Comparison fields: 5 of 33
- Transplantation 7
- Physiology 43
- Genetics 12
- Cardiology and Cardiovascular Medicine 24
- Reproductive Medicine 9
Countries citing papers authored by Alison McLean
This map shows the geographic impact of Alison McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison McLean more than expected).
Fields of papers citing papers by Alison McLean
This network shows the impact of papers produced by Alison McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison McLean. The network helps show where Alison McLean may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison McLean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 38 | |
| 2 | 2020 | 16 | |
| 3 | The emergence and popularisation of autologous somatic cellular therapies in Australia: therapeutic innovation or regulatory failure? | 2014 | 12 |
| 4 | 2022 | 11 | |
| 5 | 2010 | 9 | |
| 6 | 2022 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2015 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2021 | 0 |
About Alison McLean
Alison McLean is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Physiology, Genetics and Epidemiology, having authored 13 papers that have together received 105 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (4 papers), Genomics and Rare Diseases (3 papers), Pluripotent Stem Cells Research (3 papers), Biomedical Ethics and Regulation (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Transplantation (7 citations), Physiology (43 citations), Genetics (12 citations), Cardiology and Cardiovascular Medicine (24 citations) and Reproductive Medicine (9 citations). Alison McLean has collaborated with scholars based in Australia, Israel and Libya. Frequent co-authors include Ian Kerridge, Cameron Stewart, Fabio Luciani, Mark M. Tanaka, C. Juergens, Sonya Burgess, S. Lo, C. Mussap, Michel Tchan and Kristy Robledo. Their work appears in journals such as Stem Cell Research & Therapy, European Heart Journal, European Cardiology Review, Twin Research and Human Genetics and Journal of Theoretical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.